clearstate

Vietnam: Imaging equipment market valued at USD 87 million in 2009 with continued strong demand for NM, MR and X-ray

admin — Wed, 21 Jul 2010 09:59:21 +0000

Clearstate’s size and share diagnostics imaging equipment database is compiled from installation and sales data collected from over 1,300 healthcare facilities across 6 countries in Southeast Asia. Our databases is designed to provide granular segmentation information on unit installation and penetration of key brands by type, region and facility size. Our large sampling frame of nearly one- third of the relevant universe of facilities is one of the most comprehensive survey ever done to credibly derive the market size and share breakdown of diagnostics imaging equipment in the region. (Best viewed in full screen option)

Thirty million surgical procedures performed in China in 2010; surgery volumes expected to cross forty million by 2014

admin — Mon, 05 Jul 2010 09:18:20 +0000

Clearstate’s recent assessment of Surgical Procedure Volumes performed in China estimates a staggering 30 million procedures to be conducted in 2010. An overall growth of 6-7% is expected annually, with fastest growth seen in cardiovascular surgeries. (Best viewed in full screen option)

2009 India IVD market update: market trends, usage, perceptions

admin — Wed, 16 Jun 2010 10:25:20 +0000

India IVD market is expected to grow at an annual rate of 16% to reach a market size of USD 398 mil in 2009. All product segments are expected to grow in excess of 10%, with molecular diagnostics predicted to grow the fastest at 25%. (Best viewed in full screen option)

Enterprise Imaging Informatics: PACS in Radiology and beyond

admin — Wed, 16 Jun 2010 07:23:43 +0000

The role of medical imaging in modern healthcare is without doubt, a vital one as almost every clinical discipline utilizes it to a certain aspect. Rapid proliferation of lifestyle diseases like obesity, diabetes and hypertension due to poor diet and lack of exercise has resulted in the increasing reliance on medical imaging both for diagnostics as well as for therapeutics vis-à-vis image-guided intervention procedures, minimally invasive surgery and patient progress monitoring (e.g. response to drug treatments). (Best viewed in full screen option)

Malaysia: Imaging equipment market valued at USD 72 million in 2009 with continued strong demand for UT, MR and CV X-ray

admin — Tue, 15 Jun 2010 09:16:30 +0000

Thermometry in South East Asia: Steady growing awareness and digitization

admin — Fri, 07 May 2010 11:28:28 +0000

A recent Clearstate study revealed that the thermometer market in South-East Asia reached USD 5 mil in 2009, from approximately 2 million units sold. Interest in thermometry surged last year compared to typical years, due to a regional outbreak of H1N1 influenza. Driven by public awareness initiatives across the region, the spike in thermometer demand was particularly strong among retail consumers, and boosted sales of the more advanced thermometer types such as digital pen, infrared ear and infrared forehead. (Best viewed in full screen option)

Clearstate’s study in APAC provides analytical insights on top ophthalmic pharmaceutical suppliers.

admin — Mon, 03 May 2010 13:50:10 +0000

The APAC ophthalmic pharmaceutical markets reached USD 2.6 billion in 2008-09, with Japan taking up nearly 70% of the total market. Japan’s ophthalmic market was the first to be developed, when such international suppliers as Pfizer and Alcon entered the market some 30 years ago.

Clearstate and United BioSource Corporation launch Strategic Partnership

admin — Wed, 14 Apr 2010 12:46:06 +0000

FOR IMMEDIATE RELEASE:

Industry leaders join to offer market access solutions for biopharmaceuticals, biotechnology, and medical devices across Asia-Pacific markets

Singapore (April 14, 2010) – Clearstate Pte. Ltd. and United BioSource Corporation (UBC) today announced a strategic partnership to provide global market access, pricing and reimbursement strategies for manufacturers of biopharmaceuticals, medical devices, and other medical technology.

The agreement reinforces Clearstate’s position as the premier source for accurate and actionable market intelligence across the Asia-Pacific region and builds upon UBC’s leadership in delivering global market access strategies for life science products. The alliance provides UBC and its clients with reliable access to the highest quality market access, pricing and reimbursement information.

“UBC offers many of the industry’s leading scientific and industry experts and a unique portfolio of capabilities to support the worldwide development and commercialization of biopharmaceuticals, medical devices, and other medical technology,” said Tej Deol M.D., Clearstate’s Managing Partner. “This, agreement underscores our desire to build collaborative strategic relationships with global firms capable of providing the highest quality health care advisory services. Our relationship with UBC demonstrates our shared commitment to provide clients with the most accurate and comprehensive market intelligence for markets in the Asia Pacific region,”

“We are extremely pleased to partner with Clearstate to offer comprehensive market access strategies throughout the Asia-Pacific region,” said Lisbet Coulton, Director of International Pricing and Reimbursement at UBC. “As life science companies expand their operations throughout the Asia-Pacific region, UBC and Clearstate are ideally positioned to support their products. Our clients have been delighted with the insight and expertise provided by Clearstate and we believe our partnership offers significant value for companies seeking effective market access solutions in this region.”

About Clearstate Pte. Ltd.
Founded in 2006 and headquartered in Singapore, Clearstate is a market intelligence firm committed to the Healthcare and Life Science domains specifically within the Asia Pacific region. We offer strategic advisory and customized primary research solutions to help medical devices, healthcare services, pharmaceutical and biotechnology firms understand their current and potential markets, and implement pragmatic and innovative strategies to ultimately tap into new growth opportunities within these opaque and challenging markets. For more information about Clearstate, visit its website at www.clearstate.com.

About United BioSource Corporation
United BioSource Corporation (UBC) is a global scientific and medical affairs organization that partners with life science companies to develop and commercialize biopharmaceuticals, medical devices, and other health care technologies. We help deliver authoritative, real-world evidence to characterize product effectiveness, address safety risk, and demonstrate value. UBC brings together recognized scientific and industry experts, research operations professionals, and new technologies to provide innovative solutions across the product lifecycle. The company is headquartered in Bethesda, Maryland, with offices in North and South America, Europe and Asia. For more information about UBC, visit www.unitedbiosource.com.

For more information please email us at:

info@clearstate.com
info@unitedbiosource.com

Greater China’s IVD market reached USD 990 million in 2008 with growth led by emerging market, China

admin — Wed, 03 Mar 2010 04:45:26 +0000

The IVD segments covered by Clearstate’s study included clinical chemistry, immunochemistry, haematology, coagulation, urinalysis, microbiology, critical care and molecular diagnostics. In 2008, this market experienced a rapid growth of ~14%. This market is set to continue with its rapid pace of growth of 10%-15% in the next few years, reaching an estimated USD 1.2 – 1.3 billion in 2010.

Home-use blood pressure monitors in South East Asia: Strong near-term growth in line with disease trends

admin — Thu, 18 Feb 2010 08:20:42 +0000

In a recently concluded Clearstate study, the South East Asia market for home-use blood pressure monitors was estimated at roughly USD 13 million in 2008, from approximately 570,000 units sold. Though sales slowed in the aftermath of the global financial crisis, they are expected to pick up again. Double-digit growth—on average, at a compound annual growth rate of 15%—is expected across South East Asian countries until 2010, when the market is projected to reach roughly USD 30 million from 1.4 million units sold.